-
Something wrong with this record ?
Synthesis and antiangiogenic activity of new silybin galloyl esters
R. Gažák, K. Valentová, K. Fuksová, P. Marhol, M. Kuzma, MÁ. Medina, I. Oborná, J. Ulrichová, V. Křen,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
21928794
DOI
10.1021/jm201034h
Knihovny.cz E-resources
- MeSH
- Cell Differentiation drug effects MeSH
- Human Umbilical Vein Endothelial Cells MeSH
- Endothelial Cells drug effects physiology MeSH
- Esters MeSH
- Drug Combinations MeSH
- Angiogenesis Inhibitors chemical synthesis chemistry pharmacology MeSH
- Collagen MeSH
- Gallic Acid analogs & derivatives chemical synthesis pharmacology MeSH
- Laminin MeSH
- Humans MeSH
- Cell Movement drug effects MeSH
- Cell Proliferation drug effects MeSH
- Proteoglycans MeSH
- Silymarin analogs & derivatives chemical synthesis pharmacology MeSH
- Stereoisomerism MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The synthesis of various silybin monogalloyl esters was developed, and their antiangiogenic activities were evaluated in a variety of in vitro tests with human umbilical vein endothelial cells (HUVECs). A structure-activity relationship (SAR) study found the regioselectivity of the silybin galloylation to be highly significant. Silybin (as an equimolar mixture of two diastereomers A and B) exhibited quite poor antiangiogenic activities, whereas its B stereoisomer is more active than silybin A. The galloylation of phenolic OH groups of natural silybin (a mixture of both isomers) leads to increases in their antiangiogenic activities, which is more apparent with the 7-OH than the 20-OH. In contrast, gallates at aliphatic OH groups either had a comparable activity to the parent compound or are even worse than silybin, which was observed in the case of 3-O-galloylsilybin. The most effective compound from this series (7-O-galloylsilybin) has also been prepared from stereochemically pure silybins A and B to evaluate the effect of stereochemistry on the activity. As with silybin itself, the B isomer of 7-O-galloylsilybin was more active than the A isomer.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12022402
- 003
- CZ-PrNML
- 005
- 20170410101338.0
- 007
- ta
- 008
- 120806s2011 xxu f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1021/jm201034h $2 doi
- 035 __
- $a (PubMed)21928794
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Gažák, Radek $u Centre of Biotransformation and Biocatalysis, Institute of Microbiology Academy of Sciences of the Czech Republic, Vídeňská 1083, Prague 4, CZ 142 20, Czech Republic.
- 245 10
- $a Synthesis and antiangiogenic activity of new silybin galloyl esters / $c R. Gažák, K. Valentová, K. Fuksová, P. Marhol, M. Kuzma, MÁ. Medina, I. Oborná, J. Ulrichová, V. Křen,
- 520 9_
- $a The synthesis of various silybin monogalloyl esters was developed, and their antiangiogenic activities were evaluated in a variety of in vitro tests with human umbilical vein endothelial cells (HUVECs). A structure-activity relationship (SAR) study found the regioselectivity of the silybin galloylation to be highly significant. Silybin (as an equimolar mixture of two diastereomers A and B) exhibited quite poor antiangiogenic activities, whereas its B stereoisomer is more active than silybin A. The galloylation of phenolic OH groups of natural silybin (a mixture of both isomers) leads to increases in their antiangiogenic activities, which is more apparent with the 7-OH than the 20-OH. In contrast, gallates at aliphatic OH groups either had a comparable activity to the parent compound or are even worse than silybin, which was observed in the case of 3-O-galloylsilybin. The most effective compound from this series (7-O-galloylsilybin) has also been prepared from stereochemically pure silybins A and B to evaluate the effect of stereochemistry on the activity. As with silybin itself, the B isomer of 7-O-galloylsilybin was more active than the A isomer.
- 650 _2
- $a inhibitory angiogeneze $x chemická syntéza $x chemie $x farmakologie $7 D020533
- 650 _2
- $a buněčná diferenciace $x účinky léků $7 D002454
- 650 _2
- $a pohyb buněk $x účinky léků $7 D002465
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a kolagen $7 D003094
- 650 _2
- $a fixní kombinace léků $7 D004338
- 650 _2
- $a endoteliální buňky $x účinky léků $x fyziologie $7 D042783
- 650 _2
- $a estery $7 D004952
- 650 _2
- $a kyselina gallová $x analogy a deriváty $x chemická syntéza $x farmakologie $7 D005707
- 650 _2
- $a endoteliální buňky pupečníkové žíly (lidské) $7 D061307
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a laminin $7 D007797
- 650 _2
- $a proteoglykany $7 D011509
- 650 _2
- $a silymarin $x analogy a deriváty $x chemická syntéza $x farmakologie $7 D012838
- 650 _2
- $a stereoizomerie $7 D013237
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Valentová, Kateřina
- 700 1_
- $a Fuksová, Kateřina
- 700 1_
- $a Marhol, Petr
- 700 1_
- $a Kuzma, Marek
- 700 1_
- $a Medina, Miguel Ángel
- 700 1_
- $a Oborná, Ivana
- 700 1_
- $a Ulrichová, Jitka
- 700 1_
- $a Křen, Vladimír
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 54, č. 20 (2011), s. 7397-7407
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21928794 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120806 $b ABA008
- 991 __
- $a 20170410101636 $b ABA008
- 999 __
- $a ok $b bmc $g 944315 $s 779699
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 54 $c 20 $d 7397-7407 $e 20111003 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- LZP __
- $a Pubmed-20120806/12/01